Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion type Assertion NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_head.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion description "[These data provide compelling evidence that 17-AAG may be effective in the treatment of c-kit-related diseases including mastocytosis, GISTs, mast cell leukemia, subtypes of acute myelogenous leukemia, and testicular cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_provenance.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion evidence source_evidence_literature NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_provenance.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion SIO_000772 14551138 NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_provenance.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion wasDerivedFrom befree-20150227 NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_provenance.
- NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_assertion wasGeneratedBy ECO_0000203 NP567043.RATCP4N44f5MRA1nhjMyFGC0EANl8Sk2fUOlxAucyzt3A130_provenance.